Combination of Quercetin or/and siRNA-loaded DDAB-mPEG-PCL hybrid nanoparticles reverse resistance to Regorafenib in colon cancer cells | Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds | Alps Pharmaceutical Ind. Co.,Ltd.

Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds

Combination of Quercetin or/and siRNA-loaded DDAB-mPEG-PCL hybrid nanoparticles reverse resistance to Regorafenib in colon cancer cells

Authors:: Shabnam Shahidi; Kobra Rostamizadeh; Mojtaba Fathi; Keivan Nedaei; Ali Ramazani

Reference:: BMC Complementary Medicine and Therapies; 2022; 22; 340

DOI:: 10.1186/s12906-022-03787-8

See Abstract

Key Words:: Colon adenocarcinoma; LS-180; regorafenib; drug resistance; α5β1 integrin; quercetin; siRNA; nanoparticles; synergy

Back to index